Together with DCA and DDG Bromopyruvate is a key agent concerning metabolic approaches. Similar to DDG Bromopyruvate blocks enzymes utilizing sugar and therefore reduces the energy level as well as the resistance of an affected cell. In contrast du DDG, Bromopyruvate activates apoptothic pathways, which makes it a precious tool to enhance a wide range of different anti cancer therapies.